Analystreport

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock, up previously from $15.00.

Aurinia Pharmaceuticals Inc - Common Shares  (AUPH) 
Last aurinia pharmaceuticals inc - common shares earnings: 3/5 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.auriniapharma.com